UBS Group’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9K | Sell |
|
|||||
|
2025
Q1 | $71.9K | Buy |
|
|||||
|
2024
Q4 | $61.1K | Buy |
|
|||||
|
2024
Q3 | $14.6K | Buy |
|
|||||
|
2024
Q2 | $1.33K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $49.6K | Buy |
|
|||||
|
2023
Q3 | $1.13K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $18.2K | Sell |
|
|||||
|
2022
Q3 | $43K | Buy |
|
|||||
|
2022
Q2 | $40K | Sell |
|
|||||
|
2022
Q1 | $74K | Buy |
|
|||||
|
2021
Q4 | $62K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $0 | Buy |
|